Overview

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-06
Target enrollment:
Participant gender:
Summary
Clinical Study of DA-007 As a Treatment for Chemotherapy Induced Alopecia
Phase:
PHASE3
Details
Lead Sponsor:
Applied Biology, Inc.
Collaborators:
Daniel Alain, Inc.
Follea International Limited